Roche 2017 Net Profit Decreased Due to Impairments
February 01 2018 - 2:06AM
Dow Jones News
By Sonia Amaral Rohter
Roche Holding AG (ROG.EB) said Thursday that its 2017 net profit
decreased due to impairments of goodwill and intangible assets.
The Swiss pharmaceuticals company reported net profit for the
year of 8.83 billion Swiss francs ($9.47 billion) compared with
CHF50.58 billion in 2016. Revenue for the quarter increased 5.4% to
CHF53.3 billion, Roche said. Core operating profit increased 3.2%
to CHF19.01 billion.
Analysts surveyed by FactSet had expected full-year sales of
CHF53.15 billion.
In 2018, the company said it expects sales growth in the range
of stable to low single-digits at constant exchange rates, while
high single-digit growth is expected in core earnings per share.
Excluding the impact of U.S. tax reform, core earnings per share
are expected to grow broadly in line with sales, Roche said.
For 2017, Roche proposed a dividend of CHF8.30 a share. The
company says it expects to further increase its dividend in
2018.
Write to Sonia Amaral Rohter at
sonia.amaralrohter@dowjones.com
(END) Dow Jones Newswires
February 01, 2018 01:51 ET (06:51 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
